Cardiometabolic risk reduction in an intensive cardiovascular health program

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 7, 2013, Pages 662-669

  Voeghtly, L M ^a   Neatrour, D M ^b   Decewicz, D J ^a   Burke, A ^b   Haberkorn, M J ^b   Lechak, F ^b   Patney, H L ^a   Vernalis, M N ^c   Ellsworth, D L ^a  

^a WINDBER RESEARCH INSTITUTE   (United States)

^b Windber Medical Center   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Cardiometabolic risk; Cardiovascular disease; Exercise; Insulin; Leptin; Lifestyle modification; Low fat diet; Risk reduction

Indexed keywords

2, 4 THIAZOLIDINEDIONE DERIVATIVE; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SULFONYLUREA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET THERAPY; DISEASE COURSE; EXERCISE; FAT INTAKE; FEMALE; HEALTH PROGRAM; HUMAN; LONGITUDINAL STUDY; LOW CALORY DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MERCURY SPHYGMOMANOMETER; METABOLIC SYNDROME X; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OBESITY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; QUESTIONNAIRE; RADIOIMMUNOASSAY; RISK FACTOR; SELF HELP; SEX DIFFERENCE; SEXUAL DEVELOPMENT; TREADMILL EXERCISE; UNITED STATES; VEGETARIAN DIET;

EID: 84884702869     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.01.012     Document Type: Article

References (29)

1. Muniyappa R., Montagnani M., Koh K.K., Quon M.J. Cardiovascular actions of insulin. Endocr Rev 2007, 28:463-491.
2. Li C., Ford E.S., McGuire L.C., Mokdad A.H., Little R.R., Reaven G.M. Trends in hyperinsulinemia among nondiabetic adults in the U.S. Diabetes Care 2006, 29:2396-2402.
3. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am 2004, 33:283-303.
4. Hu G., Qiao Q., Tuomilehto J., Eliasson M., Feskens E.J., Pyörälä K., et al. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 2004, 47:1245-1256.
5. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006, 189:47-60.
6. Dubey L., Hesong Z. Role of leptin in atherogenesis. Exp Clin Cardiol 2006, 11:269-275.
7. Bouloumié A., Marumo T., Lafontan M., Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999, 13:1231-1238.
8. Sundell J., Huupponen R., Raitakari O.T., Nuutila P., Knuuti J. High serum leptin is associated with attenuated coronary vasoreactivity. Obes Res 2003, 11:776-782.
9. Sierra-Johnson J., Romero-Corral A., Lopez-Jimenez F., Gami A.S., Sert Kuniyoshi F.H., Wolk R., et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. Am J Cardiol 2007, 100:234-239.
10. Wallace A.M., McMahon A.D., Packard C.J., Kelly A., Shepherd J., Gaw A., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001, 104:3052-3056.
11. Koh K.K., Park S.M., Quon M.J. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008, 117:3238-3249.
12. Roberts C.K., Barnard R.J. Effects of exercise and diet on chronic disease. J Appl Physiol 2005, 98:3-30.
13. Tziomalos K., Dimitroula H.V., Katsiki N., Savopoulos C., Hatzitolios A.I. Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm 2010, 2010. 364957.
14. Reis J.P., Macera C.A., Wingard D.L., Araneta M.R.G., Lindsay S.P., Marshall S.J. The relation of leptin and insulin with obesity-related cardiovascular risk factors in US adults. Atherosclerosis 2008, 200:150-160.
15. Charpentier P.A., Bogardus S.T., Inouye S.K. An algorithm for prospective individual matching in a non-randomized clinical trial. J Clin Epidemiol 2001, 54:1166-1173.
16. Decewicz D.J., Neatrour D.M., Burke A., Haberkorn M.J., Patney H.L., Vernalis M.N., et al. Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy. Lipids Health Dis 2009, 8:26.
17. Des Jarlais D.C., Lyles C., Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004, 94:361-366. TREND Group.
18. Bruce R.A. Multi-stage treadmill test of submaximal and maximal exercise. Exercise testing and training of apparently healthy individuals: a handbook for physicians 1972, 32-34. American Heart Association, New York.
19. Sánchez-Margalet V., Martín-Romero C., Santos-Alvarez J., Goberna R., Najib S., Gonzalez-Yanes C. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol 2003, 133:11-19.
20. Vykoukal D., Davies M.G. Vascular biology of metabolic syndrome. J Vasc Surg 2011, 54:819-831.
21. Hooper L., Summerbell C.D., Thompson R., Sills D., Roberts F.G., Moore H., et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2011, 7:CD002137.
22. Reddigan J.I., Ardern C.I., Riddell M.C., Kuk J.L. Relation of physical activity to cardiovascular disease mortality and the influence of cardiometabolic risk factors. Am J Cardiol 2011, 108:1426-1431.
23. Guadalupe-Grau A., Perez-Gomez J., Olmedillas H., Chavarren J., Dorado C., Santana A., et al. Strength training combined with plyometric jumps in adults: sex differences infat-bone axis adaptations. J Appl Physiol 2009, 106:1100-1111.
24. Perreault L., Ma Y., Dagogo-Jack S., Horton E., Marrero D., Crandall J., et al. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care 2008, 31:1416-1421.
25. Fung T.T., Rimm E.B., Spiegelman D., Rifai N., Tofler G.H., Willett W.C., et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001, 73:61-67.
26. Winzer B.M., Whiteman D.C., Reeves M.M., Paratz J.D. Physical activity and cancer prevention: a systematic review of clinical trials. Cancer Causes Control 2011, 22:811-826.
27. Concato J., Shah N., Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000, 342:1887-1892.
28. Ioannidis J.P.A., Haidich A.-B., Pappa M., Pantazis N., Kokori S.I., Tektonidou M.G., et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001, 286:821-830.
29. Deshmukh M., Lee H.W., McFarlane S.I., Whaley-Connell A. Antihypertensive medications and their effects on lipid metabolism. Curr Diab Rep 2008, 8:214-220.